Stock detail
Roivant Sciences (ROIV) stock price, chart, and key data
View Roivant Sciences stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Roivant Sciences
ROIV · XNAS
-$0.13 (-0.45%) past month
$29.05
After hours $29.23 (+0.62%)
Key metrics
Earnings
Past Income Statement
Close price
$29.05
Market cap
$20.5B
52-week range
$10.71 - $32.79
P/E ratio
-53.8
About the company
Roivant Sciences Ltd
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app